Abstract
METHODS
We retrospectively analyzed 138 patients with poorly differentiated EGC who underwent gastrectomy with lymphadenectomy between January 1990 and December 2015. The association between the clinicopathological factors and the presence of LNM was retrospectively analyzed by univariate and multivariate logistic regression analyses. Odds ratios (OR) with 95% confidence interval (95%CI) were calculated. We further examined the relationship between the positive number of the significant predictive factors and the LNM rate.
RESULTS
The tumor diameter (OR = 13.438, 95%CI: 1.773-25.673,
INTRODUCTION
Endoscopic submucosal dissection (ESD) has become widely accepted, as it provides en bloc resection and histologically complete resection and is a valuable al ternative to gastrectomy for treating early gastric cancer (EGC) [14] . The accurate assessment of the potential pre sence of lymph node metastasis (LNM) is required for ESD. ESD can be used for EGC but it does not have the risk of LNM [57] . Because the risk of LNM is negligible (0%), ESD is often applied to well or moderately differentia ted EGC confined to the mucosa without ulceration and smaller than or equal to 2 cm [8] . For undifferentiated EGC, the risk of LNM is higher so the usage of ESD has been limited. Thus, for patients with undifferentiated EGC, gastrectomy was accepted as a standard treat ment. Undifferentiated carcinomas of gastric cancer consist of mucinous adenocarcinoma, primary signet ring cell carcinoma and poorly differentiated adenocarci noma [8] . However, approximately 96.6% of poorly di fferentiated EGC cases with potential risk of LNM are eventually found to have no LNM after "unnecessary" gastrectomy, suggesting that it may be overtreatment for these cases [9] . The new technique combines ESD with laparoscopic lymph node dissection (LLND), which may lead to the elimination of "unnecessary" gastrectomy in EGC patients having a potential risk of LNM [1013] . ESD followed by LLND enables the complete resection of the primary tumor and the histologic determination of the ly mph node status.
In this retrospective study, we determined the risk factors that were predictive of LNM in poorly differentia ted EGC patients. Our results provided some sugges tions to guide the application of combination of ESD and LLND for selected patients with poorly differentiated EGC.
MATERIALS AND METHODS

Patients
EGC is considered to be a lesion confined to the mucosa or submucosa regardless of the presence or absence of LNM, according to the Japanese Classification of Gastric Carcinoma (JCGC) [8] . This retrospective study enrolled patients who had undergone radical gastrectomy due to EGC. The patients were from the Department of Surgical Oncology, Affiliated Xing Tai People's Hospital of Hebei Medical University (Xingtai, China). Time points were from January 1990 to December 2015.
For this current study, inclusion criteria included: (1) Diagnosed with poorly differentiated EGC depending on JCGC by pathological analyses through specimens and lymph nodes; (2) Lymph node dissection beyond limit ed (D1) dissection; (3) Over sixteen lymph nodes dis sected; and (4) Available medical record from database.
During the 25 years, a total of 138 patients (87 men and 51 women) with histopathologically poorly differ entiated EGC were included for analyses. The ages of the patients ranged from 29 to 81 years (mean 49).
Dissection and classification of lymph nodes
For each patient, lymph nodes were dissected from the en bloc specimens. The classification was perfor med according to the JCGC [8] . After careful review of specimens, an experienced surgeon gave the classifi cation of the dissected lymph nodes [8] . After that, the lymph nodes were sectioned and the histopathologic and immunohistochemical features were detected by eosin and hematoxylin staining and immunohistochemistry. Pathological examination for metastasis and lymphatic vessel involvement (LVI) was detected by immunohisto chemistry with D240. We used uniform measurement standards to guarantee uniformity of treatment among the sample over the 25 years. Histologic slides were re read in a blind manner by one pathologist. The main clinical and pathological data could be obtained from ar chival documents, including surgical report, conclusions of the pathologist, and the patient card.
Association between clinicopathological parameters and LNM
In this current study, we included clinicopathological parameters according to JCGC [8] for analysis. These par ameters included family medical history of gastric cancer, gender (female, male), age (≥ 60 years, < 60 years), lymphatic vessel involvement, depth of invasion (muco sa, submucosa), macroscopic type, ulceration, tumor size (maximum dimension ≤ 2 cm, or > 2 cm), location of tumor (lower, middle, or upper stomach), number of tumors (single or multiple). As described below, the re lationship between LNM and clinicopathological factors was explored.
Statistical analysis
Chisquared test was performed to determine differen ces between patients with and without LNM in clinicopa thological parameters. After that, multivariate stepwise logistic regression analysis was carried out to identify independent risk factors for LNM. Hazard ratio and 95% confidence interval (CI) were calculated. A P value < 0.05 was considered to have statistical significance. All statistical analyses were performed using SPSS v21.0 software (IBM Corp, Armonk, NY, United States). Table 1 showed the relationship of LNM and clinicopa thological factors using a χ 2 test. Results showed that tumor diameter > 2 cm, the presence of LVI, and sub mucosal invasion were associated with a high LNM rate (P < 0.05). On the other hand, no significant association was observed between LNM and family medical history, macroscopic type, ulceration, location, number, age or gender.
RESULTS
Association between clinicopathological parameters and LNM
Potential independent risk clinicopathological parameters for LNM
Univariate analysis results demonstrated that there are three significantly associated characteristics with LNM. Multivariate analysis showed that for LNM, all three cha racteristics were independent and significant risk factors (P < 0.05, Table 2 ).
LNM in poorly differentiated EGC
Twentyone (15.2%) of 138 patients diagnosed with poorly differentiated EGC had LNM. The relationship be tween the three risk clinicopathological factors (tumor diameter > 2 cm, LVI, and submucosal invasion) and LNM was studied in poorly differentiated EGC. In poorly differentiated EGC, for patients with one, two or three ri sk factors, LNM rates were 7.7% (2/26), 47.6% (10/21) and 64.3% (9/14), respectively. For the other 77 pa tients without any of the risk factors, we did not find any LNM (Table 3) .
DISCUSSION
Endoscopic treatments, such as EMR and ESD, are st andard treatments for EGC. ESD is superior in allowing 362 WJGO|www.wjgnet.com demonstrates that poorly differentiated EGC are in ac cordance with some published studies, indicating the existence of a significant correlation between the pre sence of LVI, submucosal invasion and large tumor size with high LNM incidence [2129] . During the analysis of this study, numerous relevant subgroup analyses were also done to identify patients of whom the potential LNM can be excluded and then find the candidates who are potentially curable by ESD treatment. Interestingly, we found that patients whose tumor is confined to the intramucosa, and is less than or equal to 2 cm without LVI did not have LNM, indicating that for these cases, ESD could be sufficient and overtreatment may be avoided.
In addition, the association between the positive nu mber of the three risk factors (presence of LVI, tumor diameter > 2 cm, and submucosal invasion) and LNM rate were further studied to discuss management stra tegies for the treatment of poorly differentiated EGC. From the results of this study, we have determined that there is a certain association between LNM rate and number of significant risk factors. When the number of factors is one, two or three, LNM rates were 7.7%, 47.6% and 64.3%, respectively. Therefore, gastrecto my with lymphadenectomy is preferable for these pati ents with risk factors.
Standard gastrectomy with lymphadenectomy re mains of value as standard therapy for the potential presence of LNM in poorly differentiated EGC patients. However, the combination of ESD and LLND could avoid unnecessary gastrectomy. Studies have been reported that some patients with EGC received ESD, but the sur gery could not meet standard or expanded resection. Salvage treatment of LLND showed overall survival benefits [30, 31] . ESD has a high complete resection rate for localized primary tumor, and LLND has complementary surgical benefits, which could enable the confirmation of negative LNM [32] . Thus, this combination was a su rvival effective strategy compared to conventional tre atment. Indeed, previous data have shown that this co mbination has a significantly greater effect on overall survival during the longterm followup period [33] . The combination of ESD and LLND has fewer complications (such as perforation, etc.) and can be used in any areas in the stomach. Therefore, the combination of ESD and en bloc resection at the submucosal location, leading to accurate pathologic assessment of specimens [1416] . The dominance of ESD over surgery is less invasive, less expensive, and it better preserves physiological fun ction [17, 18] . ESD is applied to EGC without LNM, and the indication criteria for differentiated cancer. On the other hand, even though the gastric lesions can be completely removed with ESD for patients with poorly differentiated EGC, standard gastrectomy with lymph node dissection is usually performed. However, gastrectomy may be not necessary for poorly differentiated EGC patients, of which approximately 96.6% patients with surgically treatment actually do not have LNM [9] . Complications from gastrectomy are rare and not serious, including pos toperative reflux esophagitis, dumping syndrome and impaired food intake [19, 20] . If gastric lesions can be com pletely removed and lymph node status can be histo logically determined before gastrectomy, unnecessary surgery could be obviated. The new technique combines ESD with LLND, and not only completely resects the pri mary tumor but also determines the histologic status of the lymph node.
A precise prediction of the presence of LNM plays a vital role in choosing ESD for EGC. The factors that can help to predict LNM have been verified by previous studies in EGC. However, few studies have tried to ex plore whether ESD can be used in poorly differentiat ed EGC. Thus, we would like to seek a possible way to expand ESD in poorly differentiated EGC. In this study, we retrospectively examined the poorly differentiated EGC cases to confirm whether LNM could be predicted. Our data indicated that LNM has significant predictive factors, including tumor diameter > 2 cm, presence of LVI, and submucosal invasion. This present study WJGO|www.wjgnet.com LLND may be an effective, minimally invasive treatment and beneficial for long-term quality of life in poorly differentiated EGC patients. However, this study has several limitations. It was a single center study, and the sample size was relatively small. Moreover, our study was performed retrospecti vely, and the data collected were not randomized and could have been subject to associated bias. Therefore, our findings and conclusions may be not very informative to make robust conclusions. Randomized, prospe ctive studies are needed to verify these results.
In this study, we proposed a novel treatment strate gy for patients with poorly differentiated EGC ( Figure  1 ). For patients with a tumor less than or equal to 2 cm in size or when LVI is absent upon postoperative histo logical examination, ESD might be sufficient treatment. The combination of ESD and LLND enables complete resection for not only the primary tumor but also the potentially metastatic lymph node. When LLND reveals LNM or specimens of ESD shows with LVI, gastrecto my with lymphadenectomy may be a better choice to achieve R0 resection. We believe that LLND may lead to the elimination of ESD in poorly differentiated EGC patients having a potential risk of LNM.
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Research background
For patients with poorly differentiated early gastric cancer (EGC), gastrectomy with lymphadenectomy is usually performed even though the gastric lesions can be completely removed with endoscopic submucosal dissection (ESD) due to the higher risk of lymph node metastasis (LNM). However, many surgical EGC cases actually do not have LNM, indicating that this surgery may not be necessary for many cases of EGC. To avoid this unnecessary surgery, the new technique combines ESD with laparoscopic lymph node dissection (LLND), which may lead to the elimination of unnecessary gastrectomy in poorly differentiated EGC patients having a potential risk of LNM.
Research motivation
We attempted to identify a subgroup of poorly differentiated EGC patients in whom the risk of LNM can be ruled out and treated them with ESD and LLND, which may serve as a breakthrough treatment for poorly differentiated EGC.
Research objectives
In this study, we intended to determine the risk factors that were predictive of LNM in poorly differentiated EGC patients and to provide some suggestions to guide the application of the combination of ESD and LLND for selected patients with poorly differentiated EGC.
Research methods
We retrospectively analyzed 138 patients with poorly differentiated EGC who underwent gastrectomy with lymphadenectomy (between January 1990 and December 2015). We also retrospectively analyzed (by univariate and multivariate logistic regression analyses) the association between the clinicopathological factors and the presence of LNM. We further examined the relationship between the positive number of the significant predictive factors and the LNM rate.
Research results
Tumor size, depth of invasion and lymphatic vessel involvement were found to be independently risk clinicopathological factors for LNM in poorly differentiated WJGO|www.wjgnet.com 
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EGC. Furthermore, we established a simple criterion to expand the possibility of using ESD and LLND for the treatment of poorly differentiated EGC.
Research conclusions
ESD might be sufficient treatment for intramucosal poorly differentiated EGC if the tumor is less than or equal to 2 cm in size, and when lymphatic vessel involvement is absent upon postoperative histological examination. We found that the ESD with LLND may lead to the elimination of unnecessary gastrectomy in poorly differentiated EGC.
Research perspectives
The minimization of therapeutic invasiveness in order to preserve quality of life is a major topic in the management of EGC. One of the critical factors in choosing minimally invasive surgery for EGC would be the precise prediction of whether the patient has LNM. Therefore, in the future, we will carry out this retrospective study to determine the clinicopathological factors that are predictive of LNM in EGC and to guide the individual application of minimally invasive surgery in a suitable subgroup of patients with EGC.
